PropThink: SGNT Generic Leucovorin Launches; SPPI Should Absorb The News Well

[ACN Newswire] – By David MoskowitzShares of Spectrum Pharmaceuticals (NASDAQ:SPPI) have been under pressure as investors await the supply of generic leucovorin to increase and compete with SPPI’s branded cancer treatment, … more

View todays social media effects on SPPI

View the latest stocks trending across Twitter. Click to view dashboard